Pfizer appoints Cecile Guegan as its new chief financial officer, stepping into the role this month. She succeeds former CFO Dave Denton, who left the company in August.

The outlets describe the move as an internal promotion. CFO Dive emphasizes the succession timeline—highlighting Denton’s departure in August and Guegan’s appointment to take over. CNBC adds background on Guegan’s experience, describing her as a long-tenured company veteran with leadership roles over the past 20 years, and also frames the announcement alongside Pfizer’s full-year outlook.